GRSRX | RRSCX | GRSRX / RRSCX | |
Total Expense Ratio | 1.34 | 2.09 | 64% |
Annual Report Gross Expense Ratio | 1.34 | 2.17 | 62% |
Fund Existence | 11 years | 27 years | - |
Gain YTD | 8.475 | 6.165 | 137% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.01B | 376M | 534% |
Annual Yield % from dividends | 2.29 | 2.12 | 108% |
Returns for 1 year | 8.53 | 6.43 | 133% |
Returns for 3 years | 8.74 | 4.26 | 205% |
Returns for 5 years | 32.80 | 17.35 | 189% |
Returns for 10 years | 41.43 | -5.67 | -731% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WMGCX | 18.29 | 0.18 | +0.99% |
Macquarie Mid Cap Growth C | |||
GMVIX | 16.74 | 0.15 | +0.90% |
Goldman Sachs Small/Mid Cap Equity Inv | |||
SBQUX | 13.39 | 0.12 | +0.90% |
AmericaFirst Alpha Trends Factor Class U | |||
PHLCX | 12.13 | 0.06 | +0.50% |
PGIM Jennison Health Sciences C | |||
AQGNX | 12.24 | 0.02 | +0.16% |
AQR Global Equity N |